stars 1 stars 2 stars 3

Indicus Pharma is a US based pharmaceutical company, registered in the State of Delaware and headquartered in Raleigh, North Carolina. The company is focused on the development and manufacture of niche generic formulations for the US market. Niche generics are technically challenging products with limited competition in the US Generic market and generally fetch greater market share with higher returns. These products are developed using specialized technologies that can be patented. Indicus Pharma is incorporated as a strategic alliance between USV Limited, India and Dr. Nitin Sheth (President & CEO: Indicus Pharma) with the goal of capitalizing on the opportunity in the US generic industry. Our strong marketing alliance and flexible business arrangement policies help us to create long-term, reliable partners. With a full development of products suggested by our clients, we also undertake new molecule development as well as engage in co-development practices.

Indicus Pharma Questions

The Indicus Pharma annual revenue was $5.4 million in 2026.

Indicus Pharma is based in Raleigh, North Carolina.

The NAICS codes for Indicus Pharma are [325, 32, 32541, 3254].

The SIC codes for Indicus Pharma are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users